Your browser doesn't support javascript.
loading
Daily adjustment of glucocorticoids by patients with adrenal insufficiency.
Schöfl, Christof; Mayr, Bernhard; Maison, Nicole; Beuschlein, Felix; Meyer, Gesine; Badenhoop, Klaus; Kienitz, Tina; Quinkler, Marcus.
Afiliação
  • Schöfl C; Centers of Endocrinology and Metabolism, Bamberg and Erlangen, Bamberg, Germany.
  • Mayr B; Division of Endocrinology and Diabetes, Department of Medicine I, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
  • Maison N; Endocrine Research, Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-Universität, Munich, Germany.
  • Beuschlein F; Endocrine Research, Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-Universität, Munich, Germany.
  • Meyer G; Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, UniversitätsSpital Zurich, Zurich, Switzerland.
  • Badenhoop K; Division of Endocrinology and Metabolism, Department of Internal Medicine, Goethe-University Hospital, Frankfurt am Main, Germany.
  • Kienitz T; Division of Endocrinology and Metabolism, Department of Internal Medicine, Goethe-University Hospital, Frankfurt am Main, Germany.
  • Quinkler M; Endocrinology in Charlottenburg, Berlin, Germany.
Clin Endocrinol (Oxf) ; 91(2): 256-262, 2019 08.
Article em En | MEDLINE | ID: mdl-31050815
ABSTRACT

BACKGROUND:

Patients with adrenal insufficiency (AI) require lifelong glucocorticoid (GC) replacement. AI patients need to adjust GC dosage in response to stressful events and illness in order to prevent life-threatening adrenal crisis (AC).

AIM:

To evaluate self-management of patients with AI.

METHODS:

Four German centres, which are using patient's diary as part of their routine clinical practice, instructed AI patients to prospectively document any discomfort, intercurrent illness or stressful events as well as changes in GC therapy on a daily basis. Diaries of 80 patients (44 females, 52.9 ± 15.9 years, 34 primary AI) were collected and analysed. A symptom score sheet was used to evaluate severity of discomfort.

RESULTS:

In total, 34 074 patient days (93.4 years) were recorded. 4622 days with discomfort were documented. On 35% of those days (n = 1621), patients increased their GC dose (4.8% of all days). Patients who recorded discomfort had a median of four episodes of discomfort, which lasted a median of 2 days. Women documented significantly more episodes of discomfort than men (P = 0.014). Low-to-median symptom scores resulted in GC increase by 50%-60%, whereas high symptom scores and/or fever resulted in doubling GC daily dose. However, dose increase was only 55% in situations indicating gastrointestinal (GI) infection.

CONCLUSION:

Severe discomfort did not always result in dose increase, especially in GI infection. However, low symptom scores resulted in an inappropriate GC increase in some patients. This underscores an urgent need for improved training methods. Keeping daily records might be a useful tool for continued and individualized patient education.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Insuficiência Adrenal / Terapia de Reposição Hormonal / Glucocorticoides Tipo de estudo: Clinical_trials / Observational_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Insuficiência Adrenal / Terapia de Reposição Hormonal / Glucocorticoides Tipo de estudo: Clinical_trials / Observational_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article